Literature DB >> 9215152

Lancefield grouping and smell of caramel for presumptive identification and assessment of pathogenicity in the Streptococcus milleri group.

O Brogan1, J Malone, C Fox, A S Whyte.   

Abstract

AIM: To evaluate Lancefield grouping and caramel smell for presumptive identification of the Streptococcus milleri group, and to find whether Lancefield group, species, or protein profile correlated with virulence or infection site.
METHODS: Prospective studies were made of 100 consecutive streptococcal isolates in blood cultures or pus from 100 patients in whom the severity of infection was categorised as serious, moderate, or not significant. The usefulness of Lancefield group and the caramel smell for presumptive identification was examined, and the relation of the S milleri species, Lancefield group, and SDS-PAGE protein analysis to severity of infection and infection site was investigated. Lower respiratory tract and genital tract specimens, strict anaerobes, group D streptococci, and strains identified as Streptococcus pneumoniae, Streptococcus pyogenes, or Streptococcus agalactiae were excluded.
RESULTS: Most streptococci occurring in pure or significant growth density were S milleri group (87/100; 87%, 95% confidence interval 0.81-0.93). Of these, 89.7% (78/87; 0.84-0.96) were associated with infection. Lancefield group F antigen predominated (41/87; 47.1%, 0.38-0.56). Lancefield group F alone or accompanied by the caramel smell had a specificity of 100%, but a sensitivity of only 47.3% for group F alone, and 19.5% for group F accompanied by the caramel smell. There was no significant association between species, Lancefield group, and severity of infection, site of infection, or pathogenicity. SDS-PAGE analysis failed to discriminate between strains.
CONCLUSIONS: Neither species nor Lancefield antigen was related to the site of infection. The presence of Lancefield group F antigen alone or accompanied by a caramel smell was a useful indicator for the S milleri group when present, but was too insensitive to use as a screening test. Most streptococci occurring in pure culture or in significant growth density were of clinical importance. Such organisms should be identified to species level to detect the S milleri group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215152      PMCID: PMC499886          DOI: 10.1136/jcp.50.4.332

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Typing of Aeromonas species by protein fingerprinting: comparison of radiolabelling and silver staining for visualising proteins.

Authors:  S E Millership; S V Want
Journal:  J Med Microbiol       Date:  1989-05       Impact factor: 2.472

Review 2.  Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.

Authors:  J L Gómez-Garcés; J I Alós; R Cogollos
Journal:  Diagn Microbiol Infect Dis       Date:  1994-06       Impact factor: 2.803

4.  Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group".

Authors:  R A Whiley; H Fraser; J M Hardie; D Beighton
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

5.  Typing of Aeromonas species by polyacrylamide-gel electrophoresis of radiolabelled cell proteins.

Authors:  J R Stephenson; S E Millership; S Tabaqchali
Journal:  J Med Microbiol       Date:  1987-09       Impact factor: 2.472

6.  The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources.

Authors:  L C Ball; M T Parker
Journal:  J Hyg (Lond)       Date:  1979-02

7.  Detection of diacetyl (caramel odor) in presumptive identification of the "Streptococcus milleri" group.

Authors:  T A Chew; J M Smith
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 8.  Occurrence and pathogenicity of the Streptococcus milleri group.

Authors:  J Gossling
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

9.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections.

Authors:  R A Whiley; D Beighton; T G Winstanley; H Y Fraser; J M Hardie
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Identification of "Streptococcus milleri" group isolates to the species level with a commercially available rapid test system.

Authors:  C E Flynn; K L Ruoff
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more
  2 in total

1.  Species-level molecular identification of invasive "Streptococcus milleri" group clinical isolates by nucleic acid sequencing in a centralized regional microbiology laboratory.

Authors:  Peter Daley; Deirdre L Church; Daniel B Gregson; Sameer Elsayed
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Laboratory identification of Streptococcus milleri.

Authors:  R P Cooke; W A O'Neill
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.